Additional file 1 of Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease

Additional file 1: Table S1. Baseline characteristics on death and MACE risks. Table S2. Baseline characteristics on LVEF and LVMI. Table S3. Relationship between metabolites and death risk. Table S4. Relationship between metabolites and MACE risk. Table S5. Multivariate Cox proportional hazards model for clinical outcomes. Table S6. Spearman correlation analysis between clinical factors and those metabolites associated with death risk. Table S7. Spearman correlation analysis between clinical factors and those metabolites associated with death risk. Table S8. Relationship between metabolites and LVEF. Table S9. Relationship between metabolites and LVMI. Table S10. Estimation of the potential causal relationships between the metabolites and outcomes and LV remodeling traits by MR analyses. Table S11. Mediation effect of metabolites-LVEF-outcomes association. Table S12. The ionisation modes and ion pairs of the metabolites. Table S13. The coefficient of deviation of the metabolites between QC samples. Table S14. Associations between SNP and metabolites in the metabolome-based genome-wide association study.